As TSLP has been found overexpressed in serum and keratinocytes of patients with AD, activates DCs to produce IL-4, IL-5, IL-13 and TNF-α and contributes to pruritus, it is reasonable to consider as a potential therapeutic target for AD. This evidence concerns the gene IL13 and Alzheimer disease.